NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Sun Pharmaceutical Industries Ltd (SUNPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.48T, P/E ratio is 170.81, net margin is 14.8%, dividend yield is 0.86%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has a reported market cap of $4.48T (data as of 2026-07-10).
The price-to-earnings (P/E) ratio for Sun Pharmaceutical Industries Ltd (SUNPHARMA) is 170.81 (data as of 2026-07-10).
Sun Pharmaceutical Industries Ltd (SUNPHARMA) shows a reported dividend yield of 0.86%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
Sun Pharmaceutical Industries Ltd (SUNPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
SUNPHARMA is listed on NS.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) reports a net margin of 14.8% (data as of 2026-07-10).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.